Sign in Subscribe

VentureSouth

VentureSouth

VentureSouth Invests In Its 100th Startup

VentureSouth Invests In Its 100th Startup

The downturn in the venture capital landscape nationally hasn’t deterred one of the Southeast’s most active firms, VentureSouth, from placing bets in local startups. In fact, it’s actually a good time to be deploying capital, says VentureSouth’s co-founder and managing director Charlie Banks. Companies like

VentureSouth's Matt Dunbar

VentureSouth invests $9.2M in 26 early-stage startups in the Southeast

Even during a pandemic, the deals keep flowing for VentureSouth. The angel investment group, headquartered in Greenville, S.C., invested roughly $9.2 million in 26 early-stage companies in 2020. That's down from $12.7 million in 28 companies in 2019, a "record-setting" year.

Pass it Down Helps Cultural Institutions Survive Pandemic

Pass it Down Helps Cultural Institutions Survive Pandemic

COVID-19 has hit the cultural heritage industry particularly hard. Pass It Down, an award-winning digital exhibit design platform, is helping American cultural institutions withstand the pandemic, one story at a time. “Now more than ever, it’s a challenge for organizations to capture visitor attention and engage their

Raining Money Umbrella Man

Monday Fund-Day: Who Raised What in the Startup South — May 3-9

It was another $140 million week in raised capital for the South, and this time Georgia is back in the game (there’s probably a football joke there, but having attended Morehouse I’ll leave it to the Georgia Tech grads). Welcome back to Monday Fund-Day, your start-of-

Raising the Bar: RAISE Forum to Host One-Day Virtual Funding Event May 15

Raising the Bar: RAISE Forum to Host One-Day Virtual Funding Event May 15

Building Business in the Southeast Founded in 2015 by business expert Barry Etra to connect startups and investors from across the Southeast, the RAISE (Retention and Advanced Investment for the Southeast at Emory) Forum fosters collaboration within the region’s entrepreneurial ecosystem to close the funding gap. Now presented by

LabCorp-Backed Medtech Startup Predicts Outcome of Cancer Therapies On Tumors

LabCorp-Backed Medtech Startup Predicts Outcome of Cancer Therapies On Tumors

On average, it takes about eight years from the time a potential cancer drug enters clinical trials until it's approved, according to the American Cancer Society. But not every drug that's approved works with every cancer patient. Often doctors must try different therapies on the patient